Poloxamer 407 is considered safe at the concentrations found in consumer products like toothpaste, mouthwash, skincare, and some foods. It appears on the FDA’s list of substances added to food, is used as an inactive ingredient in approved medications, and the Cosmetic Ingredient Review (CIR) Expert Panel concluded it is safe as used in cosmetics. That said, some animal studies raise questions worth understanding, especially if you’ve come across alarming claims online.
What Poloxamer 407 Actually Does
Poloxamer 407 is a synthetic, non-ionic surfactant, meaning it helps oil and water mix together. In practical terms, it works as an emulsifier, stabilizer, and solubilizer across a wide range of products. In toothpaste and mouthwash, it helps distribute ingredients evenly. In skincare, it dissolves oily materials into water-based formulas. In food, it functions as a stabilizer, thickener, and surface-active agent. In wound care, it has been shown to aid healing by helping cleanse wounds, stabilize antimicrobial agents, and even repair cell membranes.
You’ll find it listed on ingredient labels under names like Pluronic F127 or simply poloxamer 407. Its widespread use comes down to the fact that it’s chemically stable, mixes well with other ingredients, and has a long track record in pharmaceutical and cosmetic formulations.
What Safety Reviews Have Found
The CIR Expert Panel, which independently reviews cosmetic ingredient safety, evaluated poloxamer 407 alongside dozens of other poloxamers and concluded they are safe as used in cosmetics. The Panel noted that poloxamer 407’s molecular weight and solubility characteristics mean very little of it penetrates through skin, and any absorption that does occur would be slow. They also noted that the manufacturing process can be controlled to limit unwanted impurities, which factored into their positive conclusion.
On the toxicology side, the oral LD50 (the dose that would be lethal to half of test animals) in rats is 5,700 mg per kilogram of body weight. To put that in perspective, that’s an extremely high threshold. Table salt has an LD50 of about 3,000 mg/kg in rats, meaning poloxamer 407 is less acutely toxic than salt on a dose-for-dose basis. Its safety data sheet classifies it as “not a hazardous substance or mixture” under the Globally Harmonised System.
Research on mouthwash formulations containing poloxamer 407 found that the compound by itself does not cause adverse effects on rat tissues. When toxic effects appeared in mouthwash testing, they were attributed to other active ingredients in the formula, not the poloxamer.
The Hyperlipidemia Concern From Animal Studies
If you’ve seen warnings about poloxamer 407 raising cholesterol or causing heart disease, those claims trace back to a specific line of animal research that requires context. When poloxamer 407 is injected directly into the bloodstream of rats and mice, it causes significant, dose-dependent spikes in both cholesterol and triglycerides. The mechanism is well understood: the compound inhibits an enzyme called lipoprotein lipase that normally clears fats from the blood, while also ramping up cholesterol production in the liver. In one study, chronic injection into mice over 145 days produced early-stage plaque buildup in the aorta.
These findings sound alarming, but the delivery method matters enormously. Researchers use poloxamer 407 injection specifically because it reliably creates a hyperlipidemia model for studying atherosclerosis. It’s a laboratory tool, not a reflection of what happens when you brush your teeth or apply a moisturizer. The amounts injected directly into the bloodstream in these studies are orders of magnitude higher than anything you’d encounter from a consumer product, and the route of exposure (intravenous injection versus swallowing trace amounts or applying something to skin) changes the biological outcome entirely.
No human studies have linked normal consumer exposure to poloxamer 407 with elevated cholesterol or cardiovascular risk.
Environmental and Long-Term Flags
The Environmental Working Group (EWG) rates poloxamer 407 with a “fair” data score, meaning the ingredient has been studied but not exhaustively. Their database flags moderate concern for environmental persistence and bioaccumulation, meaning it may not break down quickly in waterways. For human health, it receives low concern ratings for cancer, allergies, and reproductive toxicity. There is a low-to-moderate flag for non-reproductive organ system toxicity, and Environment Canada has classified it as a medium human health priority.
The CIR Panel acknowledged that reproductive and developmental toxicity data are limited. However, they judged this gap to be less concerning given how poorly the compound penetrates skin and how slowly any absorbed amount would enter the body.
Where You’re Most Likely Exposed
Your actual exposure to poloxamer 407 is almost certainly tiny. In toothpaste and mouthwash, it’s present in small percentages as a solubilizer, and most of it gets rinsed out. In skincare products like cleansers and moisturizers, it sits on the skin surface doing its emulsifying work without meaningfully absorbing. In food products, it serves as a processing aid or stabilizer at low concentrations.
If you’re using a prescription or over-the-counter medication that lists poloxamer 407 as an inactive ingredient, it’s there to help the active drug dissolve or stay evenly distributed in the formula. The FDA reviews inactive ingredients as part of the drug approval process, and poloxamer 407 has been cleared for use in numerous approved products across oral, topical, and ophthalmic formulations.
For the vast majority of people encountering poloxamer 407 in everyday products, the compound poses no meaningful health risk at the concentrations used. The dramatic effects seen in laboratory injection models do not translate to the trace exposures from brushing your teeth, washing your face, or eating processed food.